Home > Resources > Infographics > Great Expectations: Why Pharma Companies Can't Ignore Patient Services

Great Expectations: Why Pharma Companies Can't Ignore Patient Services

July 18, 2013

This survey explores what the services patients are currently getting, the ones they want expect to get and how well the industry is doing in providing those services. Patients are generally very satisfied with patient services when they get them and are willing to give more personal health information to obtain more relevant services. Satisfaction rates are high across the board ranging from a high of 80% for product information and 79% for measurement tracking and alert and a low of 63% for less available services such as access to clinical trials and financial assistance.

Spotlight

Porton Biopharma Ltd

Porton Biopharma Limited (PBL) is a UK based company experienced in developing, manufacturing and bringing to market biopharmaceutical therapeutics and vaccines. PBL was corporatised out of Public Health England on 1st April 2015 to enable us to be better placed to grow our business, which is built upon decades of biopharmaceutical experience including the successful commercialisation and licensure of many therapies which now save thousands of lives every year, and generate revenues from world-wide sales.

Other Infographics

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Great Expectations: Why Pharma Companies Can't Ignore Patient Services